HEADER TRANSCRIPTION 27-SEP-11 4A2J TITLE PR X-RAY STRUCTURES IN AGONIST CONFORMATIONS REVEAL TWO DIFFERENT TITLE 2 MECHANISMS FOR PARTIAL AGONISM IN 11BETA-SUBSTITUTED STEROIDS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGESTERONE RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 514-769; COMPND 5 SYNONYM: PR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET15B KEYWDS TRANSCRIPTION, PARTIAL AGONIST EXPDTA X-RAY DIFFRACTION AUTHOR S.J.LUSHER,H.C.A.RAAIJMAKERS,R.BOSCH,D.VU-PHAM,R.MCGUIRE,A.OUBRIE, AUTHOR 2 J.DE VLIEG REVDAT 3 07-FEB-18 4A2J 1 JRNL REMARK REVDAT 2 04-JUL-12 4A2J 1 JRNL REMARK REVDAT 1 04-APR-12 4A2J 0 JRNL AUTH S.J.LUSHER,H.C.RAAIJMAKERS,D.VU-PHAM,B.KAZEMIER,R.BOSCH, JRNL AUTH 2 R.MCGUIRE,R.AZEVEDO,H.HAMERSMA,K.DECHERING,A.OUBRIE, JRNL AUTH 3 M.VAN DUIN,J.DE VLIEG JRNL TITL X-RAY STRUCTURES OF PROGESTERONE RECEPTOR LIGAND BINDING JRNL TITL 2 DOMAIN IN ITS AGONIST STATE REVEAL DIFFERING MECHANISMS FOR JRNL TITL 3 MIXED PROFILES OF 11 BETA-SUBSTITUTED STEROIDS. JRNL REF J. BIOL. CHEM. V. 287 20333 2012 JRNL REFN ESSN 1083-351X JRNL PMID 22535964 JRNL DOI 10.1074/JBC.M111.308403 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0078 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 33483 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1821 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2437 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.3180 REMARK 3 BIN FREE R VALUE SET COUNT : 123 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4044 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 78 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.45000 REMARK 3 B22 (A**2) : 0.06000 REMARK 3 B33 (A**2) : -1.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.59000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.209 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.182 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.142 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.639 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4234 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2913 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5742 ; 1.254 ; 2.004 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7155 ; 0.880 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 502 ; 5.255 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 175 ;37.121 ;24.286 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 798 ;14.158 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;13.985 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 661 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4507 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 818 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2509 ; 0.565 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 998 ; 0.131 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4086 ; 1.046 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1725 ; 1.749 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1654 ; 2.835 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 683 A 1000 REMARK 3 ORIGIN FOR THE GROUP (A): 17.3580 -0.0090 2.0240 REMARK 3 T TENSOR REMARK 3 T11: 0.1035 T22: 0.2504 REMARK 3 T33: 0.0490 T12: -0.0217 REMARK 3 T13: -0.0132 T23: 0.0009 REMARK 3 L TENSOR REMARK 3 L11: 1.4067 L22: 2.0125 REMARK 3 L33: 2.8293 L12: 0.3099 REMARK 3 L13: -0.3704 L23: 0.8553 REMARK 3 S TENSOR REMARK 3 S11: -0.0202 S12: -0.0402 S13: 0.1493 REMARK 3 S21: 0.0787 S22: 0.1140 S23: 0.0116 REMARK 3 S31: -0.1044 S32: 0.3932 S33: -0.0938 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 683 B 1000 REMARK 3 ORIGIN FOR THE GROUP (A): -3.9800 12.3110 -33.1600 REMARK 3 T TENSOR REMARK 3 T11: 0.1461 T22: 0.0517 REMARK 3 T33: 0.0191 T12: 0.0037 REMARK 3 T13: 0.0514 T23: 0.0087 REMARK 3 L TENSOR REMARK 3 L11: 1.3945 L22: 2.8419 REMARK 3 L33: 2.0473 L12: -0.5599 REMARK 3 L13: 0.0661 L23: -0.3656 REMARK 3 S TENSOR REMARK 3 S11: -0.0450 S12: -0.0258 S13: -0.0992 REMARK 3 S21: 0.1700 S22: -0.0014 S23: 0.0104 REMARK 3 S31: 0.1270 S32: -0.0232 S33: 0.0463 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4A2J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1290049802. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35323 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 43.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.70000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-30% POLYETHYLENE GLYCOL 3350, 0.1 M REMARK 280 HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.34800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 674 REMARK 465 SER A 675 REMARK 465 HIS A 676 REMARK 465 MET A 677 REMARK 465 GLY A 678 REMARK 465 GLN A 679 REMARK 465 ASP A 680 REMARK 465 ILE A 681 REMARK 465 GLN A 682 REMARK 465 LYS A 933 REMARK 465 GLY B 674 REMARK 465 SER B 675 REMARK 465 HIS B 676 REMARK 465 MET B 677 REMARK 465 GLY B 678 REMARK 465 GLN B 679 REMARK 465 ASP B 680 REMARK 465 ILE B 681 REMARK 465 GLN B 682 REMARK 465 LYS B 933 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 932 CG CD CE NZ REMARK 470 LYS B 932 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 706 38.36 -90.86 REMARK 500 SER A 793 -2.70 83.58 REMARK 500 SER A 837 50.44 -103.60 REMARK 500 GLN A 916 -12.96 -145.71 REMARK 500 MET A 924 35.41 -93.95 REMARK 500 ASN B 705 39.38 -83.79 REMARK 500 THR B 706 -62.83 -109.36 REMARK 500 SER B 837 51.81 -100.60 REMARK 500 SER B 898 -72.51 -49.98 REMARK 500 GLN B 916 -22.89 -142.72 REMARK 500 MET B 924 33.15 -92.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ASOPRISNIL (AS0): ASOPRISNIL 4-[(11BETA,17BETA)-17-METHOXY-17- REMARK 600 (METHOXYMETHYL)-3-OXOESTRA-4,9-DIEN-11-YL]BENZALDEHYDE OXIME REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AS0 A 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AS0 B 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1934 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C7A RELATED DB: PDB REMARK 900 STRUCTURE OF THE PROGESTERONE RECEPTOR-DNA COMPLEX REMARK 900 RELATED ID: 2W8Y RELATED DB: PDB REMARK 900 RU486 BOUND TO THE PROGESTERONE RECEPTOR IN A DESTABILIZED REMARK 900 AGONISTIC CONFORMATION REMARK 900 RELATED ID: 3ZR7 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR AGONISM AND ANTAGONISM FOR A SET OF CHEMICALLY REMARK 900 RELATED PROGESTERONE RECEPTOR MODULATORS REMARK 900 RELATED ID: 1E3K RELATED DB: PDB REMARK 900 HUMAN PROGESTERON RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH REMARK 900 THE LIGAND METRIBOLONE (R1881) REMARK 900 RELATED ID: 3ZRA RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR AGONISM AND ANTAGONISM FOR A SET OF CHEMICALLY REMARK 900 RELATED PROGESTERONE RECEPTOR MODULATORS REMARK 900 RELATED ID: 3ZRB RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR AGONISM AND ANTAGONISM FOR A SET OF CHEMICALLY REMARK 900 RELATED PROGESTERONE RECEPTOR MODULATORS REMARK 900 RELATED ID: 1A28 RELATED DB: PDB REMARK 900 HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN REMARK 900 RELATED ID: 1SQN RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN WITH BOUNDNORETHINDRONE REMARK 900 RELATED ID: 1ZUC RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITHTHE REMARK 900 NONSTEROIDAL AGONIST TANAPROGET REMARK 900 RELATED ID: 1SR7 RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR HORMONE BINDING DOMAIN WITH BOUNDMOMETASONE REMARK 900 FUROATE REMARK 900 RELATED ID: 4A2K RELATED DB: PDB REMARK 900 PR X-RAY STRUCTURES IN AGONIST CONFORMATIONS REVEAL TWO DIFFERENT REMARK 900 MECHANISMS FOR PARTIAL AGONISM IN 11BETA- SUBSTITUTED STEROIDS REMARK 900 RELATED ID: 4APU RELATED DB: PDB REMARK 900 PR X-RAY STRUCTURES IN AGONIST CONFORMATIONS REVEAL TWO DIFFERENT REMARK 900 MECHANISMS FOR PARTIAL AGONISM IN 11BETA- SUBSTITUTED STEROIDS REMARK 999 REMARK 999 SEQUENCE REMARK 999 GLY SER HIS EXPRESSION TAG DBREF 4A2J A 678 933 UNP P06401 PRGR_HUMAN 514 769 DBREF 4A2J B 678 933 UNP P06401 PRGR_HUMAN 514 769 SEQADV 4A2J GLY A 674 UNP P06401 EXPRESSION TAG SEQADV 4A2J SER A 675 UNP P06401 EXPRESSION TAG SEQADV 4A2J HIS A 676 UNP P06401 EXPRESSION TAG SEQADV 4A2J MET A 677 UNP P06401 EXPRESSION TAG SEQADV 4A2J GLY B 674 UNP P06401 EXPRESSION TAG SEQADV 4A2J SER B 675 UNP P06401 EXPRESSION TAG SEQADV 4A2J HIS B 676 UNP P06401 EXPRESSION TAG SEQADV 4A2J MET B 677 UNP P06401 EXPRESSION TAG SEQRES 1 A 260 GLY SER HIS MET GLY GLN ASP ILE GLN LEU ILE PRO PRO SEQRES 2 A 260 LEU ILE ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE SEQRES 3 A 260 TYR ALA GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SEQRES 4 A 260 SER LEU LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN SEQRES 5 A 260 LEU LEU SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY SEQRES 6 A 260 PHE ARG ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE SEQRES 7 A 260 GLN TYR SER TRP MET SER LEU MET VAL PHE GLY LEU GLY SEQRES 8 A 260 TRP ARG SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR SEQRES 9 A 260 PHE ALA PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS SEQRES 10 A 260 GLU SER SER PHE TYR SER LEU CYS LEU THR MET TRP GLN SEQRES 11 A 260 ILE PRO GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU SEQRES 12 A 260 GLU PHE LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR SEQRES 13 A 260 ILE PRO LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU SEQRES 14 A 260 GLU MET ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA SEQRES 15 A 260 ILE GLY LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN SEQRES 16 A 260 ARG PHE TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS SEQRES 17 A 260 ASP LEU VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR SEQRES 18 A 260 PHE ILE GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU SEQRES 19 A 260 MET MET SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE SEQRES 20 A 260 LEU ALA GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS SEQRES 1 B 260 GLY SER HIS MET GLY GLN ASP ILE GLN LEU ILE PRO PRO SEQRES 2 B 260 LEU ILE ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE SEQRES 3 B 260 TYR ALA GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SEQRES 4 B 260 SER LEU LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN SEQRES 5 B 260 LEU LEU SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY SEQRES 6 B 260 PHE ARG ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE SEQRES 7 B 260 GLN TYR SER TRP MET SER LEU MET VAL PHE GLY LEU GLY SEQRES 8 B 260 TRP ARG SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR SEQRES 9 B 260 PHE ALA PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS SEQRES 10 B 260 GLU SER SER PHE TYR SER LEU CYS LEU THR MET TRP GLN SEQRES 11 B 260 ILE PRO GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU SEQRES 12 B 260 GLU PHE LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR SEQRES 13 B 260 ILE PRO LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU SEQRES 14 B 260 GLU MET ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA SEQRES 15 B 260 ILE GLY LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN SEQRES 16 B 260 ARG PHE TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS SEQRES 17 B 260 ASP LEU VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR SEQRES 18 B 260 PHE ILE GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU SEQRES 19 B 260 MET MET SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE SEQRES 20 B 260 LEU ALA GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS HET AS0 A1000 33 HET SO4 A1934 5 HET AS0 B1000 33 HETNAM AS0 4-[(11BETA,17BETA)-17-METHOXY-17-(METHOXYMETHYL)-3- HETNAM 2 AS0 OXOESTRA-4,9-DIEN-11-YL]BENZALDEHYDE OXIME HETNAM SO4 SULFATE ION FORMUL 3 AS0 2(C28 H35 N O4) FORMUL 4 SO4 O4 S 2- FORMUL 6 HOH *78(H2 O) HELIX 1 1 PRO A 685 ILE A 694 1 10 HELIX 2 2 THR A 710 LEU A 736 1 27 HELIX 3 3 GLY A 738 LEU A 742 5 5 HELIX 4 4 HIS A 743 SER A 772 1 30 HELIX 5 5 ASN A 785 GLU A 791 1 7 HELIX 6 6 PHE A 794 GLN A 812 1 19 HELIX 7 7 SER A 814 LEU A 827 1 14 HELIX 8 8 SER A 837 GLN A 860 1 24 HELIX 9 9 GLY A 862 GLN A 897 1 36 HELIX 10 10 GLN A 897 SER A 902 1 6 HELIX 11 11 PRO A 906 ALA A 922 1 17 HELIX 12 12 PRO B 685 GLU B 695 1 11 HELIX 13 13 THR B 710 LEU B 736 1 27 HELIX 14 14 GLY B 738 LEU B 742 5 5 HELIX 15 15 HIS B 743 SER B 772 1 30 HELIX 16 16 ASN B 785 MET B 789 5 5 HELIX 17 17 GLU B 791 TRP B 802 1 12 HELIX 18 18 TRP B 802 GLN B 812 1 11 HELIX 19 19 SER B 814 LEU B 827 1 14 HELIX 20 20 SER B 837 LEU B 858 1 22 HELIX 21 21 GLY B 862 GLN B 897 1 36 HELIX 22 22 SER B 898 LEU B 901 5 4 HELIX 23 23 PRO B 906 ALA B 922 1 17 SHEET 1 AA 2 LEU A 776 ALA A 779 0 SHEET 2 AA 2 LEU A 782 LEU A 784 -1 O LEU A 782 N ALA A 779 SHEET 1 AB 2 THR A 829 ILE A 830 0 SHEET 2 AB 2 LYS A 926 PRO A 927 -1 O LYS A 926 N ILE A 830 SHEET 1 BA 2 LEU B 776 ALA B 779 0 SHEET 2 BA 2 LEU B 782 LEU B 784 -1 O LEU B 782 N ALA B 779 SHEET 1 BB 2 THR B 829 PRO B 831 0 SHEET 2 BB 2 VAL B 925 PRO B 927 -1 O LYS B 926 N ILE B 830 SITE 1 AC1 16 LEU A 715 LEU A 718 ASN A 719 GLY A 722 SITE 2 AC1 16 GLU A 723 GLN A 725 LEU A 726 TRP A 755 SITE 3 AC1 16 MET A 759 ARG A 766 PHE A 778 PHE A 794 SITE 4 AC1 16 LEU A 797 MET A 801 CYS A 891 MET A 909 SITE 1 AC2 16 LEU B 715 LEU B 718 ASN B 719 LEU B 721 SITE 2 AC2 16 GLY B 722 GLU B 723 GLN B 725 LEU B 726 SITE 3 AC2 16 TRP B 755 MET B 759 ARG B 766 PHE B 778 SITE 4 AC2 16 MET B 801 TYR B 890 CYS B 891 MET B 909 SITE 1 AC3 5 PRO A 737 GLY A 738 ARG A 740 ASN A 741 SITE 2 AC3 5 HOH A2010 CRYST1 58.614 64.696 69.991 90.00 95.71 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017061 0.000000 0.001706 0.00000 SCALE2 0.000000 0.015457 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014359 0.00000